Press Releases

Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017

BOCA RATON, Fla., April 27, 2017 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, May 4, 2017 to discuss the […]

Sensus Healthcare issues letter to stockholders

BOCA RATON, Fla., April 24, 2017 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that Joe Sardano, chairman and chief executive officer issued today the following letter to stockholders: Dear Fellow Stockholder: Our first annual stockholders' […]

Sensus Healthcare to Present at the 29th Annual ROTH Conference

BOCA RATON, Fla., March 7, 2017 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced that Joe Sardano, the Company's chief executive officer, will present a corporate overview at the 29th Annual ROTH Conference on Wednesday, […]

Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 - 12 in Miami

-- Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 -- Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin […]

Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results

- Record Quarterly Revenues of $4.9 million in Fourth Quarter - Full Year 2016 revenues increased 44% year-over-year to $14.8 million - Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other […]

Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017

BOCA RATON, Fla., Jan. 19, 2017 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its fourth quarter and full year 2016 financial results on Thursday, February 2, 2017 […]

« Previous 1 2 3 4 5 6 7 8 9 10 … 19 20 21 22 23 24 25 26 27 28 Next »